← Back to Search
Novel spectacle lens design
New Glasses for Nearsightedness (CYPRESS Trial)
Salt Lake City, UT
N/A
Waitlist Available
Research Sponsored by SightGlass Vision, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 72 months
Summary
This trial will test if a new type of glasses can help reduce the progression of juvenile myopia, and if it is safe to use.
See full description
Who is the study for?
This trial is for kids who were in the CYPRESS study and can commit to wearing special glasses for up to 3 years, at least 10 hours a day. They shouldn't have been out of the previous study for over 30 days and must not wear contact lenses during this time. Parents or guardians need to consent.
What is being tested?
The trial tests SightGlass Vision Diffusion Optics Technology (DOT) Spectacles' long-term ability to slow down worsening near-sightedness in children compared with regular glasses, monitored over a period of three years.See study design
What are the potential side effects?
Specific side effects are not listed, but as with any eyewear, there may be discomfort or adjustment issues. The spectacles are non-invasive so significant side effects are unlikely.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 72 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~72 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Spherical equivalent refraction (SER)
Secondary study objectives
Axial length
SER
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: CYPRESS Extension Test ArmExperimental Treatment1 Intervention
Single vision, impact resistant spectacle lenses; CYPRESS Test Arm 1 and CYPRESS Test Arm 2 will move into CYPRESS Extension Test Arm
Group II: CYPRESS Extension Control ArmPlacebo Group1 Intervention
Single vision, impact resistant spectacle lenses; CYPRESS Control Arm remains in control lenses as the CYPRESS Extension Control Arm
Find a Location
Closest Location:William J Bogus, OD, FAAO· Salt Lake City, UT
Who is running the clinical trial?
SightGlass Vision, Inc.Lead Sponsor
10 Previous Clinical Trials
893 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You agree to wear the assigned spectacles constantly except for sleeping, swimming, or other activities in which spectacle wear would be dangerous or otherwise not possible (minimum of 10 hours per day).
Research Study Groups:
This trial has the following groups:- Group 1: CYPRESS Extension Control Arm
- Group 2: CYPRESS Extension Test Arm
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Near-sightedness Patient Testimony for trial: Trial Name: NCT04947735 — N/A